George Llado
Direktor/Vorstandsmitglied bei CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Vermögen: 698 066 $ am 31.05.2024
Profil
Zurzeit bekleidet George Llado die Position des Chief Information Officer & Senior Vice President von Alexion Pharmaceuticals, Inc. Herr Llado ist außerdem Mitglied des Vorstands von Charles River Laboratories International, Inc. und des National Center for Women & Information Technology. In der Vergangenheit hatte er die Position des Vice President-Manufacturing Operations bei Merck & Co, Inc. inne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.05.2024 | 3 349 ( 0,01% ) | 698 066 $ | 31.05.2024 |
Aktive Positionen von George Llado
| Unternehmen | Position | Beginn |
|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 16.10.2020 |
| National Center for Women & Information Technology | Direktor/Vorstandsmitglied | - |
TraceLink, Inc.
 TraceLink, Inc. Pharmaceuticals: MajorHealth Technology TraceLink, Inc. provides pharmaceutical serialization, drug track, trace compliance, and supply network performance solutions. It offers SupplyNexus that enables to create a collaborative supply community; ServiceLink, a collaboration platform to centrally monitor and manage track and trace. The company was founded by Peter Monahan, Graham Clark, Shabbir Mansur Dahod, Peter J. Spellman, Luciana Deus, John Kordash and Brian Daleiden in 2009 and is headquartered in North Reading, MA. | Direktor/Vorstandsmitglied | 18.05.2023 |
Ehemalige bekannte Positionen von George Llado
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Commercial Services |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| National Center for Women & Information Technology | |
TraceLink, Inc.
TraceLink, Inc. Pharmaceuticals: MajorHealth Technology TraceLink, Inc. provides pharmaceutical serialization, drug track, trace compliance, and supply network performance solutions. It offers SupplyNexus that enables to create a collaborative supply community; ServiceLink, a collaboration platform to centrally monitor and manage track and trace. The company was founded by Peter Monahan, Graham Clark, Shabbir Mansur Dahod, Peter J. Spellman, Luciana Deus, John Kordash and Brian Daleiden in 2009 and is headquartered in North Reading, MA. | Health Technology |
